Zoono Group Ltd News

Zoono Group Places Additional Shares to OSY Group

Biotech company Zoono Group (ASX:ZNO) placed an additional 13.6 million fully paid ordinary shares at AU$0.027 per share to OSY Group, according to a Friday filing with the Australian Securities Excha

MT NewswiresMay 16 21:19 ET

Zoono Group Raises Maximum Amount Under the Rights Issue; Shares Jump 7%

Biotech company Zoono Group (ASX:ZNO) raised roughly AU$2.9 million, which was the maximum possible amount under its rights issue, according to a Wednesday filing with the Australian Securities Exchan

MT NewswiresMay 8 00:10 ET

Evolution Capital, OSY Group to Underwrite Zoono Group's AU$2.9 Million Rights Issue

Global biotech company Zoono Group's (ASX:ZNO) up to AU$2.9 million rights issue of one new share for every two existing shares held on the record date at AU$0.027 will be underwritten by lead manager

MT NewswiresMar 25 22:55 ET

Zoono Group Says Unaware of Any Information for Share Price Fluctuation

Zoono Group (ASX:ZNO) said it was unaware of any information as to why its share price ranged between AU$0.044 and AU$0.069 in Tuesday's session, according to a same-day filing with the Australian bou

MT NewswiresMar 19 03:38 ET

Zoono Group Signs Exclusive Deal for Sale Promotion for Products; Shares Up 8%

Zoono Group (ASX:ZNO) entered into an exclusive agency agreement with OSY Group for the promotion of the sale of the biotechnology company's products for the food supply chain sector. The agreement ha

MT NewswiresMar 5 23:26 ET

Zoono Group Delays Start of Up to AU$2.7 Million Rights Issue

Biotechnology company Zoono Group (ASX:ZNO) delayed the commencement of a nonrenounceable rights issue of 101,030,281 at AU$0.027 per share, by several weeks, citing external circumstances. Proceeds o

MT NewswiresJan 30 21:29 ET

Zoono Group Faces Charges From the New Zealand Commerce Commission

Zoono Group (ASX:ZNO) said on Wednesday that the company is facing charges filed by the New Zealand Commerce Commission over its marketing claims relating to the longevity and effectiveness of its san

MT NewswiresDec 20, 2023 20:46 ET